All news

Pic:getty/kotofeja

AC Immune acquires Parkinson’s vaccine candidate

By Rachel Arthur

AC Immune will acquire Affiris’ portfolio of therapeutics targeting alpha-synuclein (a-syn), which includes a vaccine candidate for the treatment of Parkinson’s disease.

Follow us

Products

View more

Webinars